Company intelligence / Profile preview

Shanghai Jiyan Bio-pharmaceutical

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Jiyan Bio is a Shanghai-based biotechnology company focused on the discovery and development of innovative small molecule drugs targeting "undruggable" proteins. The company utilizes a proprietary structural biology and computational chemistry platform to design high-affinity ligands for complex protein-protein interactions (PPIs). Their primary therapeutic focus is oncology, with a pipeline featuring inhibitors for key signaling pathways like KRAS and SOS1. Founded by experts in structural biology from Tsinghua University, Jiyan Bio aims to address significant unmet medical needs in cancer treatment through precision medicine and structure-based drug design.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Shanghai Jiyan Bio-pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Jiyan Bio-pharmaceutical.

Explore the full profile